Hepatitis C related mortality in GBD: Methods Summary and Updates for GBD 2019

Hepatitis C related mortality in GBD: Methods Summary and Updates for GBD 2019

November 9 2020
77 minutes
Webinar series
Strategic Information Collaborative
Video URL

Dr. Dirac provides an overview on updates to the Global Burden of Disease (GBD) methodology for estimating HCV-related mortality.

 

The content of the presentation included:

  • Methods used to estimate mortality related to hepatitis C in GBD
  • Changes to methods between GBD 2017 and GBD 2019
  • Expected changes in results between GBD 2017 and GBD 2019

Full GBD 2019 results were released on October 15th. The full results are available here and a summary of the 2019 HCV-related burden of disease is available here. 

For more information about this webinar series, contact the Coalition at globalhep [at] taskforce.org

For more information about the Global Burden of Disease Study, contact Dr. Mae Dirac at madirac [at] uw.edu

 

Dr. Mae Dirac, MD, PhD
Reproductive, Genitourinary and Digestive Disease Estimation Team Lead for the Global Burden of Disease Study, Acting Assistant Professor, University of Washington